CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1242432/full #Morpholino